Velda Smajlbegović

Statistics

Publications

Citations

H-Index

Active since

2020

Affiliations

Velda Smajlbegović is an author at University of Sarajevo specializing in oncology, adaptive radiotherapy dose prescription, and regional nodal irradiation.

ORCID

Publications per year

2020–2022

Publications

Non-phosphorylated Tyr-1248 form of human epidermal growth factor receptor 2 (HER2) predicts resistance to trastuzumab therapy and poor disease-free survival of HER2-positive breast cancer patients

Snježana Ramić, Frane Paić, Velda Smajlbegović et al. · Croatian Medical Journal · 2022 · 15 citations · Full text

Medicine, Oncology, Pharmacology +16

Adaptive radiotherapy for head and neck cancer

Enis Tinjak, Velda Smajlbegović, Adnan Beganović et al. · Radiološke tehnologije · 2020 · 13 citations · Full text

Medicine, Oncology, Radiation Oncology +15

1–2 of 2